{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ferroptosis", "liver injury", "phytochemical", "polysaccharide"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35684103", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "30"}], "Language": ["eng"], "ELocationID": ["2303", "10.3390/nu14112303"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "14", "Issue": "11", "PubDate": {"Year": "2022", "Month": "May", "Day": "30"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases.", "Abstract": {"AbstractText": ["Liver disease is a global health burden with high morbidity and mortality worldwide. Liver injuries can develop into severe end-stage diseases, such as cirrhosis or hepatocellular carcinoma, without valid treatment. Therefore, identifying novel drugs may promote liver disease treatment. Phytochemicals, including polysaccharides, flavonoids, alkaloids, and terpenes, are abundant in foods and medicinal plants and have various bioactivities, such as antioxidation, immunoregulation, and tumor killing. Recent studies have shown that many natural polysaccharides play protective roles in liver disease models in vitro and in vivo, such as fatty liver disease, alcoholic liver disease, drug-induced liver injury, and liver cancer. The mechanisms of liver disease are complex. Notably, ferroptosis, a new type of cell death driven by iron and lipid peroxidation, is considered to be the key mechanism in many hepatic pathologies. Therefore, polysaccharides and other types of phytochemicals with activities in ferroptosis regulation provide novel therapeutic strategies for ferroptosis-related liver diseases. This review summarizes our current understanding of the mechanisms of ferroptosis and liver injury and compelling preclinical evidence of natural bioactive polysaccharides and phytochemicals in treating liver disease."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, Precision Nutrition Innovation Center, School of Public Health, Zhengzhou University, Zhengzhou 450001, China."}], "LastName": "Ren", "ForeName": "Yijing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, Precision Nutrition Innovation Center, School of Public Health, Zhengzhou University, Zhengzhou 450001, China."}], "LastName": "Li", "ForeName": "Siyue", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, Precision Nutrition Innovation Center, School of Public Health, Zhengzhou University, Zhengzhou 450001, China."}], "LastName": "Song", "ForeName": "Zixuan", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, Precision Nutrition Innovation Center, School of Public Health, Zhengzhou University, Zhengzhou 450001, China."}], "LastName": "Luo", "ForeName": "Qiuping", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, Precision Nutrition Innovation Center, School of Public Health, Zhengzhou University, Zhengzhou 450001, China."}], "LastName": "Zhang", "ForeName": "Yingying", "Initials": "Y"}, {"Identifier": ["0000-0001-7661-3688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, Precision Nutrition Innovation Center, School of Public Health, Zhengzhou University, Zhengzhou 450001, China."}], "LastName": "Wang", "ForeName": "Hao", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Polysaccharides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Ferroptosis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Polysaccharides"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Marcellin P., Kutala B.K. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver. Int. 2018;38((Suppl. 1)):2\u20136. doi: 10.1111/liv.13682.", "ArticleIdList": ["10.1111/liv.13682", "29427496"]}, {"Citation": "Wong M.C.S., Huang J.L.W., George J., Huang J., Leung C., Eslam M., Chan H.L.Y., Ng S.C. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat. Rev. Gastroenterol. Hepatol. 2019;16:57\u201373. doi: 10.1038/s41575-018-0055-0.", "ArticleIdList": ["10.1038/s41575-018-0055-0", "30158570"]}, {"Citation": "Udompap P., Kim D., Kim W.R. Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin. Gastroenterol. Hepatol. 2015;13:2031\u20132041. doi: 10.1016/j.cgh.2015.08.015.", "ArticleIdList": ["10.1016/j.cgh.2015.08.015", "PMC4618163", "26291665"]}, {"Citation": "Asrani S.K., Hall L., Hagan M., Sharma S., Yeramaneni S., Trotter J., Talwalkar J., Kanwal F. Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study. Am. J. Gastroenterol. 2019;114:98\u2013106. doi: 10.1038/s41395-018-0365-4.", "ArticleIdList": ["10.1038/s41395-018-0365-4", "30333543"]}, {"Citation": "Choudhari A.S., Mandave P.C., Deshpande M., Ranjekar P., Prakash O. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front. Pharmacol. 2019;10:1614. doi: 10.3389/fphar.2019.01614.", "ArticleIdList": ["10.3389/fphar.2019.01614", "PMC7025531", "32116665"]}, {"Citation": "Guan R., van Le Q., Yang H., Zhang D., Gu H., Yang Y., Sonne C., Lam S.S., Zhong J., Jianguang Z., et al. A review of dietary phytochemicals and their relation to oxidative stress and human diseases. Chemosphere. 2021;271:129499. doi: 10.1016/j.chemosphere.2020.129499.", "ArticleIdList": ["10.1016/j.chemosphere.2020.129499", "33445014"]}, {"Citation": "Abd Rashid N., Abd Halim S.A.S., Teoh S.L., Budin S.B., Hussan F., Adib Ridzuan N.R., Abdul Jalil N.A. The role of natural antioxidants in cisplatin-induced hepatotoxicity. Biomed. Pharmacother. 2021;144:112328. doi: 10.1016/j.biopha.2021.112328.", "ArticleIdList": ["10.1016/j.biopha.2021.112328", "34653753"]}, {"Citation": "Dhahri M., Alghrably M., Mohammed H.A., Badshah S.L., Noreen N., Mouffouk F., Rayyan S., Qureshi K.A., Mahmood D., Lachowicz J.I., et al. Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases. Pharmaceutics. 2021;14:1. doi: 10.3390/pharmaceutics14010001.", "ArticleIdList": ["10.3390/pharmaceutics14010001", "PMC8777698", "35056897"]}, {"Citation": "Dong X., Zhou M., Li Y., Li Y., Ji H., Hu Q. Cardiovascular Protective Effects of Plant Polysaccharides: A Review. Front. Pharmacol. 2021;12:783641. doi: 10.3389/fphar.2021.783641.", "ArticleIdList": ["10.3389/fphar.2021.783641", "PMC8639026", "34867415"]}, {"Citation": "Li Y., Qin J., Cheng Y., Lv D., Li M., Qi Y., Lan J., Zhao Q., Li Z. Marine Sulfated Polysaccharides: Preventive and Therapeutic Effects on Metabolic Syndrome: A Review. Mar. Drugs. 2021;19:608. doi: 10.3390/md19110608.", "ArticleIdList": ["10.3390/md19110608", "PMC8618309", "34822479"]}, {"Citation": "Yuan Y., Che L., Qi C., Meng Z. Protective effects of polysaccharides on hepatic injury: A review. Int. J. Biol. Macromol. 2019;141:822\u2013830. doi: 10.1016/j.ijbiomac.2019.09.002.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.09.002", "31487518"]}, {"Citation": "Qu J., Huang P., Zhang L., Qiu Y., Qi H., Leng A., Shang D. Hepatoprotective effect of plant polysaccharides from natural resources: A review of the mechanisms and structure-activity relationship. Int. J. Biol. Macromol. 2020;161:24\u201334. doi: 10.1016/j.ijbiomac.2020.05.196.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.05.196", "32485257"]}, {"Citation": "Ouyang Y., Qiu Y., Liu Y., Zhu R., Chen Y., El-Seedi H.R., Chen X., Zhao C. Cancer-fighting potentials of algal polysaccharides as nutraceuticals. Food Res. Int. 2021;147:110522. doi: 10.1016/j.foodres.2021.110522.", "ArticleIdList": ["10.1016/j.foodres.2021.110522", "34399500"]}, {"Citation": "Zhang H., Jiang F., Zhang J., Wang W., Li L., Yan J. Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review. Int. J. Biol. Macromol. 2022;204:169\u2013192. doi: 10.1016/j.ijbiomac.2022.01.166.", "ArticleIdList": ["10.1016/j.ijbiomac.2022.01.166", "35122806"]}, {"Citation": "Wang B., Wang X., Xiong Z., Lu G., Ma W., Lv Q., Wang L., Jia X., Feng L. A review on the applications of Traditional Chinese medicine polysaccharides in drug delivery systems. Chin. Med. 2022;17:12. doi: 10.1186/s13020-021-00567-3.", "ArticleIdList": ["10.1186/s13020-021-00567-3", "PMC8760834", "35033122"]}, {"Citation": "Xie M., Tao W., Wu F., Wu K., Huang X., Ling G., Zhao C., Lv Q., Wang Q., Zhou X., et al. Anti-hypertensive and cardioprotective activities of traditional Chinese medicine-derived polysaccharides: A review. Int. J. Biol. Macromol. 2021;185:917\u2013934. doi: 10.1016/j.ijbiomac.2021.07.008.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.07.008", "34229020"]}, {"Citation": "Friedman S.L., Neuschwander-Tetri B.A., Rinella M., Sanyal A.J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 2018;24:908\u2013922. doi: 10.1038/s41591-018-0104-9.", "ArticleIdList": ["10.1038/s41591-018-0104-9", "PMC6553468", "29967350"]}, {"Citation": "Brunt E.M., Wong V.W., Nobili V., Day C.P., Sookoian S., Maher J.J., Bugianesi E., Sirlin C.B., Neuschwander-Tetri B.A., Rinella M.E. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Primers. 2015;1:15080. doi: 10.1038/nrdp.2015.80.", "ArticleIdList": ["10.1038/nrdp.2015.80", "27188459"]}, {"Citation": "Nabi O., Boursier J., Lacombe K., Mathurin P., de Ledinghen V., Goldberg M., Zins M., Serfaty L. Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study) Dig. Dis. Sci. 2021 doi: 10.1007/s10620-021-07032-z.", "ArticleIdList": ["10.1007/s10620-021-07032-z", "34031802"]}, {"Citation": "Wang F.S., Fan J.G., Zhang Z., Gao B., Wang H.Y. The global burden of liver disease: The major impact of China. Hepatology. 2014;60:2099\u20132108. doi: 10.1002/hep.27406.", "ArticleIdList": ["10.1002/hep.27406", "PMC4867229", "25164003"]}, {"Citation": "Huang D.Q., El-Serag H.B., Loomba R. Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 2021;18:223\u2013238. doi: 10.1038/s41575-020-00381-6.", "ArticleIdList": ["10.1038/s41575-020-00381-6", "PMC8016738", "33349658"]}, {"Citation": "Buzzetti E., Pinzani M., Tsochatzis E.A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) Metabolism. 2016;65:1038\u20131048. doi: 10.1016/j.metabol.2015.12.012.", "ArticleIdList": ["10.1016/j.metabol.2015.12.012", "26823198"]}, {"Citation": "Pohl K., Moodley P., Dhanda A.D. Alcohol's Impact on the Gut and Liver. Nutrients. 2021;13:3170. doi: 10.3390/nu13093170.", "ArticleIdList": ["10.3390/nu13093170", "PMC8472839", "34579046"]}, {"Citation": "Rehm J., Taylor B., Mohapatra S., Irving H., Baliunas D., Patra J., Roerecke M. Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis. Drug Alcohol Rev. 2010;29:437\u2013445. doi: 10.1111/j.1465-3362.2009.00153.x.", "ArticleIdList": ["10.1111/j.1465-3362.2009.00153.x", "20636661"]}, {"Citation": "Michalak A., Lach T., Cichoz-Lach H. Oxidative Stress-A Key Player in the Course of Alcohol-Related Liver Disease. J. Clin. Med. 2021;10:3011. doi: 10.3390/jcm10143011.", "ArticleIdList": ["10.3390/jcm10143011", "PMC8303854", "34300175"]}, {"Citation": "Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol. Aspects Med. 2008;29:9\u201316. doi: 10.1016/j.mam.2007.09.004.", "ArticleIdList": ["10.1016/j.mam.2007.09.004", "18045675"]}, {"Citation": "Tilg H., Moschen A.R., Kaneider N.C. Pathways of liver injury in alcoholic liver disease. J. Hepatol. 2011;55:1159\u20131161. doi: 10.1016/j.jhep.2011.05.015.", "ArticleIdList": ["10.1016/j.jhep.2011.05.015", "21723837"]}, {"Citation": "Chen L., Zhang L., Wang W., Qiu W., Liu L., Ning A., Cao J., Huang M., Zhong M. Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet. PLoS ONE. 2020;15:e0232972. doi: 10.1371/journal.pone.0232972.", "ArticleIdList": ["10.1371/journal.pone.0232972", "PMC7279895", "32512581"]}, {"Citation": "Feng Y., Li H., Chen C., Lin H., Xu G., Li H., Wang C., Chen J., Sun J. Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics. Front. Pharmacol. 2021;12:727636. doi: 10.3389/fphar.2021.727636.", "ArticleIdList": ["10.3389/fphar.2021.727636", "PMC8490749", "34621168"]}, {"Citation": "Li M., Ma J., Ahmad O., Cao Y., Wang B., He Q., Li J., Yin H., Zhang Y., He J., et al. Lipid-modulate activity of Cichorium glandulosum Boiss. et Huet polysaccharide in nonalcoholic fatty liver disease larval zebrafish model. J. Pharmacol. Sci. 2018;138:257\u2013262. doi: 10.1016/j.jphs.2018.09.012.", "ArticleIdList": ["10.1016/j.jphs.2018.09.012", "30482436"]}, {"Citation": "Ren R., Yang Z., Zhao A., Huang Y., Lin S., Gong J., Chen J., Zhu P., Huang F., Lin W. Sulfated polysaccharide from Enteromorpha prolifera increases hydrogen sulfide production and attenuates non-alcoholic fatty liver disease in high-fat diet rats. Food Funct. 2018;9:4376\u20134383. doi: 10.1039/C8FO00518D.", "ArticleIdList": ["10.1039/C8FO00518D", "30051131"]}, {"Citation": "Shih P.H., Shiue S.J., Chen C.N., Cheng S.W., Lin H.Y., Wu L.W., Wu M.S. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis. Mar. Drugs. 2021;19:148. doi: 10.3390/md19030148.", "ArticleIdList": ["10.3390/md19030148", "PMC8001566", "33809062"]}, {"Citation": "Wang F., Tipoe G.L., Yang C., Nanji A.A., Hao X., So K.F., Xiao J. Lycium barbarum Polysaccharide Supplementation Improves Alcoholic Liver Injury in Female Mice by Inhibiting Stearoyl-CoA Desaturase 1. Mol. Nutr. Food Res. 2018;62:e1800144. doi: 10.1002/mnfr.201800144.", "ArticleIdList": ["10.1002/mnfr.201800144", "29797417"]}, {"Citation": "Wang K.L., Lu Z.M., Mao X., Chen L., Gong J.S., Ren Y., Geng Y., Li H., Xu H.Y., Xu G.H., et al. Structural characterization and anti-alcoholic liver injury activity of a polysaccharide from Coriolus versicolor mycelia. Int. J. Biol. Macromol. 2019;137:1102\u20131111. doi: 10.1016/j.ijbiomac.2019.06.242.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.06.242", "31276724"]}, {"Citation": "Wang X., Shi L., Wang X., Feng Y., Wang Y. MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. Int. J. Biol. Macromol. 2019;141:1013\u20131021. doi: 10.1016/j.ijbiomac.2019.09.007.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.09.007", "31491513"]}, {"Citation": "Wu J., Shao H., Zhang J., Ying Y., Cheng Y., Zhao D., Dou X., Lv H., Li S., Liu F., et al. Mussel polysaccharide alpha-d-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways. Int. J. Biol. Macromol. 2019;130:68\u201378. doi: 10.1016/j.ijbiomac.2019.02.097.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.02.097", "30797009"]}, {"Citation": "Wu Y., Zhou F., Jiang H., Wang Z., Hua C., Zhang Y. Chicory (Cichorium intybus L.) polysaccharides attenuate high-fat diet induced non-alcoholic fatty liver disease via AMPK activation. Int. J. Biol. Macromol. 2018;118:886\u2013895. doi: 10.1016/j.ijbiomac.2018.06.140.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.06.140", "29964102"]}, {"Citation": "Zhong D., Xie Z., Huang B., Zhu S., Wang G., Zhou H., Lin S., Lin Z., Yang B. Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF. Cell Physiol. Biochem. 2018;49:1163\u20131179. doi: 10.1159/000493297.", "ArticleIdList": ["10.1159/000493297", "30196282"]}, {"Citation": "Zhu H., Wang Z., Wu Y., Jiang H., Zhou F., Xie X., Wang R., Hua C. Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease. Int. J. Biol. Macromol. 2019;128:363\u2013375. doi: 10.1016/j.ijbiomac.2019.01.141.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.01.141", "30690116"]}, {"Citation": "Zou C., Fang Y., Lin N., Liu H. Polysaccharide extract from pomelo fruitlet ameliorates diet-induced nonalcoholic fatty liver disease in hybrid grouper (Epinephelus lanceolatusmale symbol x Epinephelus fuscoguttatusfemale symbol) Fish Shellfish Immunol. 2021;119:114\u2013127. doi: 10.1016/j.fsi.2021.09.034.", "ArticleIdList": ["10.1016/j.fsi.2021.09.034", "34607007"]}, {"Citation": "Hu B., Yang H., Chen G., Sun X., Zou X., Ma J., Yao X., Liang Q., Liu H. Structural characterization and preventive effect on non-alcoholic fatty liver disease of oligosaccharides from Bletilla striata. Food Funct. 2022;13:4757\u20134769. doi: 10.1039/D1FO03899K.", "ArticleIdList": ["10.1039/D1FO03899K", "35389416"]}, {"Citation": "Hasenour C.M., Berglund E.D., Wasserman D.H. Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver. Mol. Cell Endocrinol. 2013;366:152\u2013162. doi: 10.1016/j.mce.2012.06.018.", "ArticleIdList": ["10.1016/j.mce.2012.06.018", "PMC3538936", "22796337"]}, {"Citation": "Ruderman N.B., Xu X.J., Nelson L., Cacicedo J.M., Saha A.K., Lan F., Ido Y. AMPK and SIRT1: A long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 2010;298:E751\u2013E760. doi: 10.1152/ajpendo.00745.2009.", "ArticleIdList": ["10.1152/ajpendo.00745.2009", "PMC2853213", "20103737"]}, {"Citation": "Huang X., Liu G., Guo J., Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 2018;14:1483\u20131496. doi: 10.7150/ijbs.27173.", "ArticleIdList": ["10.7150/ijbs.27173", "PMC6158718", "30263000"]}, {"Citation": "Wang K., Cao P., Wang H., Tang Z., Wang N., Wang J., Zhang Y. Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice. Sci. Rep. 2016;6:26229. doi: 10.1038/srep26229.", "ArticleIdList": ["10.1038/srep26229", "PMC4870572", "27189109"]}, {"Citation": "Kong X., Liang W., Li X., Qiu M., Xu W., Chen H. Characterization of an Acidic Polysaccharides from Carrot and Its Hepatoprotective Effect on Alcoholic Liver Injury in Mice. Chem. Biodivers. 2021;18:e2100359. doi: 10.1002/cbdv.202100359.", "ArticleIdList": ["10.1002/cbdv.202100359", "34170621"]}, {"Citation": "Wang C., Zheng L., Liu S., Guo X., Qu Y., Gao M., Cui X., Yang Y. A novel acidic polysaccharide from the residue of Panax notoginseng and its hepatoprotective effect on alcoholic liver damage in mice. Int. J. Biol. Macromol. 2020;149:1084\u20131097. doi: 10.1016/j.ijbiomac.2020.02.034.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.02.034", "32035151"]}, {"Citation": "Zhao H., Li H., Lai Q., Yang Q., Dong Y., Liu X., Wang W., Zhang J., Jia L. Antioxidant and hepatoprotective activities of modified polysaccharides from Coprinus comatus in mice with alcohol-induced liver injury. Int. J. Biol. Macromol. 2019;127:476\u2013485. doi: 10.1016/j.ijbiomac.2019.01.067.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.01.067", "30659878"]}, {"Citation": "Wang X.Y., Luo J.P., Chen R., Zha X.Q., Wang H. The effects of daily supplementation of Dendrobium huoshanense polysaccharide on ethanol-induced subacute liver injury in mice by proteomic analysis. Food Funct. 2014;5:2020\u20132035. doi: 10.1039/C3FO60629E.", "ArticleIdList": ["10.1039/C3FO60629E", "24933018"]}, {"Citation": "Jiang W., Zhu H., Xu W., Liu C., Hu B., Guo Y., Cheng Y., Qian H. Echinacea purpurea polysaccharide prepared by fractional precipitation prevents alcoholic liver injury in mice by protecting the intestinal barrier and regulating liver-related pathways. Int. J. Biol. Macromol. 2021;187:143\u2013156. doi: 10.1016/j.ijbiomac.2021.07.095.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.07.095", "34293362"]}, {"Citation": "Nepali S., Ki H.H., Lee J.H., Cha J.Y., Lee Y.M., Kim D.K. Triticum aestivum sprout-derived polysaccharide exerts hepatoprotective effects against ethanol-induced liver damage by enhancing the antioxidant system in mice. Int. J. Mol. Med. 2017;40:1243\u20131252. doi: 10.3892/ijmm.2017.3095.", "ArticleIdList": ["10.3892/ijmm.2017.3095", "28849040"]}, {"Citation": "Qu H., Gao X., Wang Z.Y., Yi J.J. Comparative study on hepatoprotection of pine nut (Pinus koraiensis Sieb. et Zucc.) polysaccharide against different types of chemical-induced liver injury models in vivo. Int. J. Biol. Macromol. 2020;155:1050\u20131059. doi: 10.1016/j.ijbiomac.2019.11.069.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.11.069", "31712149"]}, {"Citation": "Song X., Liu Z., Zhang J., Zhang C., Dong Y., Ren Z., Gao Z., Liu M., Zhao H., Jia L. Antioxidative and hepatoprotective effects of enzymatic and acidic-hydrolysis of Pleurotus geesteranus mycelium polysaccharides on alcoholic liver diseases. Carbohydr. Polym. 2018;201:75\u201386. doi: 10.1016/j.carbpol.2018.08.058.", "ArticleIdList": ["10.1016/j.carbpol.2018.08.058", "30241865"]}, {"Citation": "Song X., Sun W., Cui W., Jia L., Zhang J. A polysaccharide of PFP-1 from Pleurotus geesteranus attenuates alcoholic liver diseases via Nrf2 and NF-kappaB signaling pathways. Food Funct. 2021;12:4591\u20134605. doi: 10.1039/D1FO00310K.", "ArticleIdList": ["10.1039/D1FO00310K", "33908547"]}, {"Citation": "Xiao J., Zhu Y., Liu Y., Tipoe G.L., Xing F., So K.F. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway. Int. J. Biol. Macromol. 2014;69:73\u201378. doi: 10.1016/j.ijbiomac.2014.05.034.", "ArticleIdList": ["10.1016/j.ijbiomac.2014.05.034", "24858535"]}, {"Citation": "Yang K., Zhan L., Lu T., Zhou C., Chen X., Dong Y., Lv G., Chen S. Dendrobium officinale polysaccharides protected against ethanol-induced acute liver injury in vivo and in vitro via the TLR4/NF-kappaB signaling pathway. Cytokine. 2020;130:155058. doi: 10.1016/j.cyto.2020.155058.", "ArticleIdList": ["10.1016/j.cyto.2020.155058", "32222695"]}, {"Citation": "Zhang L., Zhao Q., Wang L., Zhao M., Zhao B. Protective effect of polysaccharide from maca (Lepidium meyenii) on Hep-G2 cells and alcoholic liver oxidative injury in mice. Int. J. Biol. Macromol. 2017;99:63\u201370. doi: 10.1016/j.ijbiomac.2017.01.125.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.01.125", "28174084"]}, {"Citation": "Zhao H., Zhang J., Liu X., Yang Q., Dong Y., Jia L. The antioxidant activities of alkalic-extractable polysaccharides from Coprinus comatus on alcohol-induced liver injury in mice. Sci. Rep. 2018;8:11695. doi: 10.1038/s41598-018-30104-6.", "ArticleIdList": ["10.1038/s41598-018-30104-6", "PMC6076309", "30076364"]}, {"Citation": "Wang Y., Guan M., Zhao X., Li X. Effects of garlic polysaccharide on alcoholic liver fibrosis and intestinal microflora in mice. Pharm. Biol. 2018;56:325\u2013332. doi: 10.1080/13880209.2018.1479868.", "ArticleIdList": ["10.1080/13880209.2018.1479868", "PMC6130653", "29969576"]}, {"Citation": "Song X., Cui W., Meng F., Xia Q., Li X., Hou M., Jia L., Zhang J. Glucopyranose from Pleurotus geesteranus prevent alcoholic liver diseases by regulating Nrf2/HO-1-TLR4/NF-kappaB signalling pathways and gut microbiota. Food Funct. 2022;13:2441\u20132455. doi: 10.1039/D1FO03486C.", "ArticleIdList": ["10.1039/D1FO03486C", "35048917"]}, {"Citation": "Kisseleva T., Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 2021;18:151\u2013166. doi: 10.1038/s41575-020-00372-7.", "ArticleIdList": ["10.1038/s41575-020-00372-7", "33128017"]}, {"Citation": "Meurer S.K., Karsdal M.A., Weiskirchen R. Advances in the clinical use of collagen as biomarker of liver fibrosis. Expert Rev. Mol. Diagn. 2020;20:947\u2013969. doi: 10.1080/14737159.2020.1814746.", "ArticleIdList": ["10.1080/14737159.2020.1814746", "32865433"]}, {"Citation": "Tacke F., Trautwein C. Mechanisms of liver fibrosis resolution. J. Hepatol. 2015;63:1038\u20131039. doi: 10.1016/j.jhep.2015.03.039.", "ArticleIdList": ["10.1016/j.jhep.2015.03.039", "26232376"]}, {"Citation": "Ying-Mei K.E., Min J., Shu-Bo Z., Hong Y.U., Juan W., Feng G.E. Component analysis of Ophiocordyceps lanpingensis polysaccharides and study on alleviation of hepatic fibrosis in mice by polysaccharides. Zhongguo Zhong Yao Za Zhi. 2020;45:5256\u20135264. doi: 10.19540/j.cnki.cjcmm.20200628.401.", "ArticleIdList": ["10.19540/j.cnki.cjcmm.20200628.401", "33350243"]}, {"Citation": "Wang G., Zuo P., Ding K., Zeng Q., Hu T., Wei S., Luo P. Intervention Study of Dictyophora Polysaccharides on Arsenic-Induced Liver Fibrosis in SD Rats. Biomed. Res. Int. 2022;2022:7509620. doi: 10.1155/2022/7509620.", "ArticleIdList": ["10.1155/2022/7509620", "PMC8986371", "35402611"]}, {"Citation": "Wang K., Wang J., Song M., Wang H., Xia N., Zhang Y. Angelica sinensis polysaccharide attenuates CCl4-induced liver fibrosis via the IL-22/STAT3 pathway. Int. J. Biol. Macromol. 2020;162:273\u2013283. doi: 10.1016/j.ijbiomac.2020.06.166.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.06.166", "32569681"]}, {"Citation": "Zhangdi H.J., Su S.B., Wang F., Liang Z.Y., Yan Y.D., Qin S.Y., Jiang H.X. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J. Gastroenterol. 2019;25:4835\u20134849. doi: 10.3748/wjg.v25.i33.4835.", "ArticleIdList": ["10.3748/wjg.v25.i33.4835", "PMC6737310", "31543677"]}, {"Citation": "Luedde T., Schwabe R.F. NF-kappaB in the liver\u2014Linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2011;8:108\u2013118. doi: 10.1038/nrgastro.2010.213.", "ArticleIdList": ["10.1038/nrgastro.2010.213", "PMC3295539", "21293511"]}, {"Citation": "Liu X., Pang H., Gao Z., Zhao H., Zhang J., Jia L. Antioxidant and hepatoprotective activities of residue polysaccharides by Pleurotus citrinipileatus. Int. J. Biol. Macromol. 2019;131:315\u2013322. doi: 10.1016/j.ijbiomac.2019.03.074.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.03.074", "30872051"]}, {"Citation": "Nishimura N., Kaji K., Kitagawa K., Sawada Y., Furukawa M., Ozutsumi T., Fujinaga Y., Tsuji Y., Takaya H., Kawaratani H., et al. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. Int. J. Mol. Sci. 2021;22:6921. doi: 10.3390/ijms22136921.", "ArticleIdList": ["10.3390/ijms22136921", "PMC8267717", "34203178"]}, {"Citation": "Gao L.L., Ma J.M., Fan Y.N., Zhang Y.N., Ge R., Tao X.J., Zhang M.W., Gao Q.H., Yang J.J. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation. Int. J. Biol. Macromol. 2021;183:1379\u20131392. doi: 10.1016/j.ijbiomac.2021.05.066.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.05.066", "33992651"]}, {"Citation": "Wang G., Yang X., Wang J., Zhong D., Zhang R., Zhang Y., Feng L., Zhang Y. Walnut green husk polysaccharides prevent obesity, chronic inflammatory responses, nonalcoholic fatty liver disease and colonic tissue damage in high-fat diet fed rats. Int. J. Biol. Macromol. 2021;182:879\u2013898. doi: 10.1016/j.ijbiomac.2021.04.047.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.04.047", "33857511"]}, {"Citation": "Wang W., Xu A.L., Li Z.C., Li Y., Xu S.F., Sang H.C., Zhi F. Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. Diabetes Metab. J. 2020;44:336\u2013348. doi: 10.4093/dmj.2019.0042.", "ArticleIdList": ["10.4093/dmj.2019.0042", "PMC7188963", "31950772"]}, {"Citation": "Gao L.L., Li Y.X., Ma J.M., Guo Y.Q., Li L., Gao Q.H., Fan Y.N., Zhang M.W., Tao X.J., Yu J.Q., et al. Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: Study protocol for a randomized controlled trial. Trials. 2021;22:566. doi: 10.1186/s13063-021-05529-6.", "ArticleIdList": ["10.1186/s13063-021-05529-6", "PMC8439032", "34521466"]}, {"Citation": "Wang K., Yang X., Wu Z., Wang H., Li Q., Mei H., You R., Zhang Y. Dendrobium officinale Polysaccharide Protected CCl4-Induced Liver Fibrosis Through Intestinal Homeostasis and the LPS-TLR4-NF-kappaB Signaling Pathway. Front. Pharmacol. 2020;11:240. doi: 10.3389/fphar.2020.00240.", "ArticleIdList": ["10.3389/fphar.2020.00240", "PMC7080991", "32226380"]}, {"Citation": "McGlynn K.A., Petrick J.L., El-Serag H.B. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021;73((Suppl. 1)):4\u201313. doi: 10.1002/hep.31288.", "ArticleIdList": ["10.1002/hep.31288", "PMC7577946", "32319693"]}, {"Citation": "Miao L., Zhang Z., Ren Z., Li Y. Application of Immunotherapy in Hepatocellular Carcinoma. Front. Oncol. 2021;11:699060. doi: 10.3389/fonc.2021.699060.", "ArticleIdList": ["10.3389/fonc.2021.699060", "PMC8426571", "34513678"]}, {"Citation": "Khinsar K.H., Abdul S., Hussain A., Ud Din R., Lei L., Cao J., Abbasi M., Ur Rehman A., Farooqui N., Yi X., et al. Anti-tumor effect of polysaccharide from Pleurotus ostreatus on H22 mouse Hepatoma ascites in-vivo and hepatocellular carcinoma in-vitro model. AMB Express. 2021;11:160. doi: 10.1186/s13568-021-01314-5.", "ArticleIdList": ["10.1186/s13568-021-01314-5", "PMC8640000", "34855004"]}, {"Citation": "Lai X., Xia W., Wei J., Ding X. Therapeutic Effect of Astragalus Polysaccharides on Hepatocellular Carcinoma H22-Bearing Mice. Dose Response. 2017;15:1559325816685182. doi: 10.1177/1559325816685182.", "ArticleIdList": ["10.1177/1559325816685182", "PMC5298564", "28210201"]}, {"Citation": "Song M., Li Z.H., Gu H.S., Tang R.Y., Zhang R., Zhu Y.L., Liu J.L., Zhang J.J., Wang L.Y. Ganoderma lucidum Spore Polysaccharide Inhibits the Growth of Hepatocellular Carcinoma Cells by Altering Macrophage Polarity and Induction of Apoptosis. J. Immunol. Res. 2021;2021:6696606. doi: 10.1155/2021/6696606.", "ArticleIdList": ["10.1155/2021/6696606", "PMC7954632", "33748291"]}, {"Citation": "Parmar D., Apte M. Angiopoietin inhibitors: A review on targeting tumor angiogenesis. Eur. J. Pharmacol. 2021;899:174021. doi: 10.1016/j.ejphar.2021.174021.", "ArticleIdList": ["10.1016/j.ejphar.2021.174021", "33741382"]}, {"Citation": "Ren F., Wu K., Yang Y., Yang Y., Wang Y., Li J. Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1alpha Expression. Front. Pharmacol. 2020;11:460. doi: 10.3389/fphar.2020.00460.", "ArticleIdList": ["10.3389/fphar.2020.00460", "PMC7158757", "32322211"]}, {"Citation": "Cheng W., Cheng Z., Weng L., Xing D., Zhang M. Asparagus Polysaccharide inhibits the Hypoxia-induced migration, invasion and angiogenesis of Hepatocellular Carcinoma Cells partly through regulating HIF1alpha/VEGF expression via MAPK and PI3K signaling pathway. J. Cancer. 2021;12:3920\u20133929. doi: 10.7150/jca.51407.", "ArticleIdList": ["10.7150/jca.51407", "PMC8176233", "34093799"]}, {"Citation": "Cheng W., Cheng Z., Xing D., Zhang M. Asparagus Polysaccharide Suppresses the Migration, Invasion, and Angiogenesis of Hepatocellular Carcinoma Cells Partly by Targeting the HIF-1alpha/VEGF Signalling Pathway In Vitro. Evid Based Complement. Alternat. Med. 2019;2019:3769879. doi: 10.1155/2019/3769879.", "ArticleIdList": ["10.1155/2019/3769879", "PMC6556301", "31239858"]}, {"Citation": "Chu G., Miao Y., Huang K., Song H., Liu L. Role and Mechanism of Rhizopus Nigrum Polysaccharide EPS1-1 as Pharmaceutical for Therapy of Hepatocellular Carcinoma. Front. Bioeng. Biotechnol. 2020;8:509. doi: 10.3389/fbioe.2020.00509.", "ArticleIdList": ["10.3389/fbioe.2020.00509", "PMC7296140", "32582655"]}, {"Citation": "Liang M., Liu J., Ji H., Chen M., Zhao Y., Li S., Zhang X., Li J. A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo. Tumour Biol. 2015;36:7085\u20137091. doi: 10.1007/s13277-015-3420-4.", "ArticleIdList": ["10.1007/s13277-015-3420-4", "25874498"]}, {"Citation": "Ma D., Wei J., Chen S., Wang H., Ning L., Luo S.H., Liu C.L., Song G., Yao Q. Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression. Front. Oncol. 2021;11:653902. doi: 10.3389/fonc.2021.653902.", "ArticleIdList": ["10.3389/fonc.2021.653902", "PMC8078595", "33928038"]}, {"Citation": "Shen W., Chen C., Guan Y., Song X., Jin Y., Wang J., Hu Y., Xin T., Jiang Q., Zhong L. A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells. Int. J. Biol. Macromol. 2017;104:681\u2013686. doi: 10.1016/j.ijbiomac.2017.06.078.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.06.078", "28634059"]}, {"Citation": "Wang Y., Wang S., Song R., Cai J., Xu J., Tang X., Li N. Ginger polysaccharides induced cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Int. J. Biol. Macromol. 2019;123:81\u201390. doi: 10.1016/j.ijbiomac.2018.10.169.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.10.169", "30414900"]}, {"Citation": "Yu J., Liu C., Ji H.Y., Liu A.J. The caspases-dependent apoptosis of hepatoma cells induced by an acid-soluble polysaccharide from Grifola frondosa. Int. J. Biol. Macromol. 2020;159:364\u2013372. doi: 10.1016/j.ijbiomac.2020.05.095.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.05.095", "32422265"]}, {"Citation": "Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J. Gastroenterol. 2009;15:513\u2013520. doi: 10.3748/wjg.15.513.", "ArticleIdList": ["10.3748/wjg.15.513", "PMC2653340", "19195051"]}, {"Citation": "Liu Z., Ke F., Duan C., Lan H., Li J., Gao C., Li J., Zhong Z. Mannan-conjugated adenovirus enhanced gene therapy effects on murine hepatocellular carcinoma cells in vitro and in vivo. Bioconjug. Chem. 2013;24:1387\u20131397. doi: 10.1021/bc400215a.", "ArticleIdList": ["10.1021/bc400215a", "23937094"]}, {"Citation": "Zhang Y., Li Q., Wang J., Cheng F., Huang X., Cheng Y., Wang K. Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma. Cancer Lett. 2016;377:117\u2013125. doi: 10.1016/j.canlet.2016.04.037.", "ArticleIdList": ["10.1016/j.canlet.2016.04.037", "27130669"]}, {"Citation": "Zong S., Li J., Yang L., Huang Q., Hou G., Ye Z., Ye M. Mechanism of bioactive polysaccharide from Lachnum sp. acts synergistically with 5-fluorouracil against human hepatocellular carcinoma. J. Cell Physiol. 2019;234:15548\u201315562. doi: 10.1002/jcp.28202.", "ArticleIdList": ["10.1002/jcp.28202", "30770552"]}, {"Citation": "Zong S., Li J., Yang L., Huang Q., Ye Z., Hou G., Ye M. Synergistic antitumor effect of polysaccharide from Lachnum sp. in combination with cyclophosphamide in hepatocellular carcinoma. Carbohydr. Polym. 2018;196:33\u201346. doi: 10.1016/j.carbpol.2018.05.006.", "ArticleIdList": ["10.1016/j.carbpol.2018.05.006", "29891303"]}, {"Citation": "Liu Y.H., Qin H.Y., Zhong Y.Y., Li S., Wang H.J., Wang H., Chen L.L., Tang X., Li Y.L., Qian Z.Y., et al. Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice. BMC Cancer. 2021;21:37. doi: 10.1186/s12885-020-07742-z.", "ArticleIdList": ["10.1186/s12885-020-07742-z", "PMC7792036", "33413214"]}, {"Citation": "Yao F., Jiang G.R., Liang G.Q., Yuan Q., Zhu Y., Liu M., Zhang L.R. The antitumor effect of the combination of aconitine and crude monkshood polysaccharide on hepatocellular carcinoma. Pak. J. Pharm. Sci. 2021;34:971\u2013979.", "ArticleIdList": ["34602421"]}, {"Citation": "Zhang Y., Cui Z., Mei H., Xu J., Zhou T., Cheng F., Wang K. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer. Carbohydr. Polym. 2019;219:143\u2013154. doi: 10.1016/j.carbpol.2019.04.041.", "ArticleIdList": ["10.1016/j.carbpol.2019.04.041", "31151511"]}, {"Citation": "Liu X., Wu Z., Guo C., Guo H., Su Y., Chen Q., Sun C., Liu Q., Chen D., Mu H. Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy. Drug Deliv. 2022;29:138\u2013148. doi: 10.1080/10717544.2021.2021324.", "ArticleIdList": ["10.1080/10717544.2021.2021324", "PMC8725898", "34967268"]}, {"Citation": "Andrade R.J., Chalasani N., Bjornsson E.S., Suzuki A., Kullak-Ublick G.A., Watkins P.B., Devarbhavi H., Merz M., Lucena M.I., Kaplowitz N., et al. Drug-induced liver injury. Nat. Rev. Dis. Primers. 2019;5:58. doi: 10.1038/s41572-019-0105-0.", "ArticleIdList": ["10.1038/s41572-019-0105-0", "31439850"]}, {"Citation": "Cao P., Sun J., Sullivan M.A., Huang X., Wang H., Zhang Y., Wang N., Wang K. Angelica sinensis polysaccharide protects against acetaminophen-induced acute liver injury and cell death by suppressing oxidative stress and hepatic apoptosis in vivo and in vitro. Int. J. Biol. Macromol. 2018;111:1133\u20131139. doi: 10.1016/j.ijbiomac.2018.01.139.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.01.139", "29415408"]}, {"Citation": "Che J., Yang S., Qiao Z., Li H., Sun J., Zhuang W., Chen J., Wang C. Schisandra chinensis acidic polysaccharide partialy reverses acetaminophen-induced liver injury in mice. J. Pharmacol. Sci. 2019;140:248\u2013254. doi: 10.1016/j.jphs.2019.07.008.", "ArticleIdList": ["10.1016/j.jphs.2019.07.008", "31400930"]}, {"Citation": "Chen C., Liu X., Qi S., A C.P.D., Yan J., Zhang X. Hepatoprotective effect of Phellinus linteus mycelia polysaccharide (PL-N1) against acetaminophen-induced liver injury in mouse. Int. J. Biol. Macromol. 2020;154:1276\u20131284. doi: 10.1016/j.ijbiomac.2019.11.002.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.11.002", "31758991"]}, {"Citation": "Wang X., Liu J., Zhang X., Zhao S., Zou K., Xie J., Wang X., Liu C., Wang J., Wang Y. Seabuckthorn berry polysaccharide extracts protect against acetaminophen induced hepatotoxicity in mice via activating the Nrf-2/HO-1-SOD-2 signaling pathway. Phytomedicine. 2018;38:90\u201397. doi: 10.1016/j.phymed.2017.11.007.", "ArticleIdList": ["10.1016/j.phymed.2017.11.007", "29425659"]}, {"Citation": "Wang Y.Q., Wei J.G., Tu M.J., Gu J.G., Zhang W. Fucoidan Alleviates Acetaminophen-Induced Hepatotoxicity via Oxidative Stress Inhibition and Nrf2 Translocation. Int. J. Mol. Sci. 2018;19:4050. doi: 10.3390/ijms19124050.", "ArticleIdList": ["10.3390/ijms19124050", "PMC6321350", "30558169"]}, {"Citation": "Dong Y., Huang J., Lin X., Zhang S., Jiao Y., Liang T., Chen Z., Huang R. Hepatoprotective effects of Yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice. J. Ethnopharmacol. 2014;152:201\u2013206. doi: 10.1016/j.jep.2014.01.001.", "ArticleIdList": ["10.1016/j.jep.2014.01.001", "24412379"]}, {"Citation": "Wang J., Luo W., Li B., Lv J., Ke X., Ge D., Dong R., Wang C., Han Y., Zhang C., et al. Sagittaria sagittifolia polysaccharide protects against isoniazid- and rifampicin-induced hepatic injury via activation of nuclear factor E2-related factor 2 signaling in mice. J. Ethnopharmacol. 2018;227:237\u2013245. doi: 10.1016/j.jep.2018.09.002.", "ArticleIdList": ["10.1016/j.jep.2018.09.002", "30194055"]}, {"Citation": "Zhang G.L., Wang Y.H., Ni W., Teng H.L., Lin Z.B. Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J. Gastroenterol. 2002;8:728\u2013733. doi: 10.3748/wjg.v8.i4.728.", "ArticleIdList": ["10.3748/wjg.v8.i4.728", "PMC4656329", "12174387"]}, {"Citation": "Luedde T., Kaplowitz N., Schwabe R.F. Cell death and cell death responses in liver disease: Mechanisms and clinical relevance. Gastroenterology. 2014;147:765\u2013783.e764. doi: 10.1053/j.gastro.2014.07.018.", "ArticleIdList": ["10.1053/j.gastro.2014.07.018", "PMC4531834", "25046161"]}, {"Citation": "Singh R., Letai A., Sarosiek K. Regulation of apoptosis in health and disease: The balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 2019;20:175\u2013193. doi: 10.1038/s41580-018-0089-8.", "ArticleIdList": ["10.1038/s41580-018-0089-8", "PMC7325303", "30655609"]}, {"Citation": "Bock F.J., Tait S.W.G. Mitochondria as multifaceted regulators of cell death. Nat. Rev. Mol. Cell Biol. 2020;21:85\u2013100. doi: 10.1038/s41580-019-0173-8.", "ArticleIdList": ["10.1038/s41580-019-0173-8", "31636403"]}, {"Citation": "Bonora M., Giorgi C., Pinton P. Molecular mechanisms and consequences of mitochondrial permeability transition. Nat. Rev. Mol. Cell Biol. 2021;23:266\u2013285. doi: 10.1038/s41580-021-00433-y.", "ArticleIdList": ["10.1038/s41580-021-00433-y", "34880425"]}, {"Citation": "Dixon S.J., Lemberg K.M., Lamprecht M.R., Skouta R., Zaitsev E.M., Gleason C.E., Patel D.N., Bauer A.J., Cantley A.M., Yang W.S., et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u20131072. doi: 10.1016/j.cell.2012.03.042.", "ArticleIdList": ["10.1016/j.cell.2012.03.042", "PMC3367386", "22632970"]}, {"Citation": "Jiang X., Stockwell B.R., Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 2021;22:266\u2013282. doi: 10.1038/s41580-020-00324-8.", "ArticleIdList": ["10.1038/s41580-020-00324-8", "PMC8142022", "33495651"]}, {"Citation": "Wenzel S.E., Tyurina Y.Y., Zhao J., St Croix C.M., Dar H.H., Mao G., Tyurin V.A., Anthonymuthu T.S., Kapralov A.A., Amoscato A.A., et al. PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell. 2017;171:628\u2013641.e626. doi: 10.1016/j.cell.2017.09.044.", "ArticleIdList": ["10.1016/j.cell.2017.09.044", "PMC5683852", "29053969"]}, {"Citation": "Chen J., Li X., Ge C., Min J., Wang F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29:467\u2013480. doi: 10.1038/s41418-022-00941-0.", "ArticleIdList": ["10.1038/s41418-022-00941-0", "PMC8901678", "35075250"]}, {"Citation": "Fang X., Wang H., Han D., Xie E., Yang X., Wei J., Gu S., Gao F., Zhu N., Yin X., et al. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl. Acad. Sci. USA. 2019;116:2672\u20132680. doi: 10.1073/pnas.1821022116.", "ArticleIdList": ["10.1073/pnas.1821022116", "PMC6377499", "30692261"]}, {"Citation": "Wang H., An P., Xie E., Wu Q., Fang X., Gao H., Zhang Z., Li Y., Wang X., Zhang J., et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology. 2017;66:449\u2013465. doi: 10.1002/hep.29117.", "ArticleIdList": ["10.1002/hep.29117", "PMC5573904", "28195347"]}, {"Citation": "Yu Y., Jiang L., Wang H., Shen Z., Cheng Q., Zhang P., Wang J., Wu Q., Fang X., Duan L., et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 2020;136:726\u2013739. doi: 10.1182/blood.2019002907.", "ArticleIdList": ["10.1182/blood.2019002907", "PMC7414596", "32374849"]}, {"Citation": "Fang X., Cai Z., Wang H., Han D., Cheng Q., Zhang P., Gao F., Yu Y., Song Z., Wu Q., et al. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis. Circ. Res. 2020;127:486\u2013501. doi: 10.1161/CIRCRESAHA.120.316509.", "ArticleIdList": ["10.1161/CIRCRESAHA.120.316509", "32349646"]}, {"Citation": "Gao M., Yi J., Zhu J., Minikes A.M., Monian P., Thompson C.B., Jiang X. Role of Mitochondria in Ferroptosis. Mol. Cell. 2019;73:354\u2013363.e353. doi: 10.1016/j.molcel.2018.10.042.", "ArticleIdList": ["10.1016/j.molcel.2018.10.042", "PMC6338496", "30581146"]}, {"Citation": "Ingold I., Berndt C., Schmitt S., Doll S., Poschmann G., Buday K., Roveri A., Peng X., Porto Freitas F., Seibt T., et al. Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell. 2018;172:409\u2013422.e421. doi: 10.1016/j.cell.2017.11.048.", "ArticleIdList": ["10.1016/j.cell.2017.11.048", "29290465"]}, {"Citation": "Mao C., Liu X., Zhang Y., Lei G., Yan Y., Lee H., Koppula P., Wu S., Zhuang L., Fang B., et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u2013590. doi: 10.1038/s41586-021-03539-7.", "ArticleIdList": ["10.1038/s41586-021-03539-7", "PMC8895686", "33981038"]}, {"Citation": "Yang W.S., SriRamaratnam R., Welsch M.E., Shimada K., Skouta R., Viswanathan V.S., Cheah J.H., Clemons P.A., Shamji A.F., Clish C.B., et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u2013331. doi: 10.1016/j.cell.2013.12.010.", "ArticleIdList": ["10.1016/j.cell.2013.12.010", "PMC4076414", "24439385"]}, {"Citation": "Doll S., Freitas F.P., Shah R., Aldrovandi M., da Silva M.C., Ingold I., Goya Grocin A., Xavier da Silva T.N., Panzilius E., Scheel C.H., et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u2013698. doi: 10.1038/s41586-019-1707-0.", "ArticleIdList": ["10.1038/s41586-019-1707-0", "31634899"]}, {"Citation": "Shimada K., Hayano M., Pagano N.C., Stockwell B.R. Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity. Cell Chem. Biol. 2016;23:225\u2013235. doi: 10.1016/j.chembiol.2015.11.016.", "ArticleIdList": ["10.1016/j.chembiol.2015.11.016", "PMC4792701", "26853626"]}, {"Citation": "Yang L., Wang H., Yang X., Wu Q., An P., Jin X., Liu W., Huang X., Li Y., Yan S., et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal. Transduct. Target. Ther. 2020;5:138. doi: 10.1038/s41392-020-00253-0.", "ArticleIdList": ["10.1038/s41392-020-00253-0", "PMC7393508", "32732975"]}, {"Citation": "Yang W.S., Kim K.J., Gaschler M.M., Patel M., Shchepinov M.S., Stockwell B.R. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. USA. 2016;113:E4966\u2013E4975. doi: 10.1073/pnas.1603244113.", "ArticleIdList": ["10.1073/pnas.1603244113", "PMC5003261", "27506793"]}, {"Citation": "Zou Y., Henry W.S., Ricq E.L., Graham E.T., Phadnis V.V., Maretich P., Paradkar S., Boehnke N., Deik A.A., Reinhardt F., et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585:603\u2013608. doi: 10.1038/s41586-020-2732-8.", "ArticleIdList": ["10.1038/s41586-020-2732-8", "PMC8051864", "32939090"]}, {"Citation": "Doll S., Proneth B., Tyurina Y.Y., Panzilius E., Kobayashi S., Ingold I., Irmler M., Beckers J., Aichler M., Walch A., et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 2017;13:91\u201398. doi: 10.1038/nchembio.2239.", "ArticleIdList": ["10.1038/nchembio.2239", "PMC5610546", "27842070"]}, {"Citation": "He S., Li R., Peng Y., Wang Z., Huang J., Meng H., Min J., Wang F., Ma Q. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke. J. Cachexia Sarcopenia Muscle. 2022 doi: 10.1002/jcsm.12953.", "ArticleIdList": ["10.1002/jcsm.12953", "PMC9178366", "35243801"]}, {"Citation": "Wu J., Minikes A.M., Gao M., Bian H., Li Y., Stockwell B.R., Chen Z.N., Jiang X. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572:402\u2013406. doi: 10.1038/s41586-019-1426-6.", "ArticleIdList": ["10.1038/s41586-019-1426-6", "PMC6697195", "31341276"]}, {"Citation": "Chen J., Ding C., Chen Y., Hu W., Yu C., Peng C., Feng X., Cheng Q., Wu W., Lu Y., et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Cancer Lett. 2021;502:154\u2013165. doi: 10.1016/j.canlet.2020.12.019.", "ArticleIdList": ["10.1016/j.canlet.2020.12.019", "33340617"]}, {"Citation": "Du X., Zhang J., Liu L., Xu B., Han H., Dai W., Pei X., Fu X., Hou S. A novel anticancer property of Lycium barbarum polysaccharide in triggering ferroptosis of breast cancer cells. J. Zhejiang Univ. Sci. B. 2022;23:286\u2013299. doi: 10.1631/jzus.B2100748.", "ArticleIdList": ["10.1631/jzus.B2100748", "PMC9002246", "35403384"]}, {"Citation": "Lo A.C.Y., Yang M. Lycium barbarum polysaccharides and ferroptosis: Jumping into the era of novel regulated cell death. Neural Regen. Res. 2022;17:1473\u20131474. doi: 10.4103/1673-5374.330600.", "ArticleIdList": ["10.4103/1673-5374.330600", "PMC8771082", "34916422"]}, {"Citation": "Zhai F.G., Liang Q.C., Wu Y.Y., Liu J.Q., Liu J.W. Red ginseng polysaccharide exhibits anticancer activity through GPX4 downregulation-induced ferroptosis. Pharm. Biol. 2022;60:909\u2013914. doi: 10.1080/13880209.2022.2066139.", "ArticleIdList": ["10.1080/13880209.2022.2066139", "PMC9116236", "35575436"]}, {"Citation": "Chen Y., Wang J., Li J., Zhu J., Wang R., Xi Q., Wu H., Shi T., Chen W. Astragalus polysaccharide prevents ferroptosis in a murine model of experimental colitis and human Caco-2 cells via inhibiting NRF2/HO-1 pathway. Eur. J. Pharmacol. 2021;911:174518. doi: 10.1016/j.ejphar.2021.174518.", "ArticleIdList": ["10.1016/j.ejphar.2021.174518", "34562468"]}, {"Citation": "Dorschmann P., Apitz S., Hellige I., Neupane S., Alban S., Kopplin G., Ptak S., Frette X., Roider J., Zille M., et al. Evaluation of the Effects of Fucoidans from Fucus Species and Laminaria hyperborea against Oxidative Stress and Iron-Dependent Cell Death. Mar. Drugs. 2021;19:557. doi: 10.3390/md19100557.", "ArticleIdList": ["10.3390/md19100557", "PMC8538076", "34677456"]}, {"Citation": "Li W., Zhou X., Xu S., Cao N., Li B., Chen W., Yang B., Yuan M., Xu D. Lipopolysaccharide-induced splenic ferroptosis in goslings was alleviated by polysaccharide of atractylodes macrocephala koidz associated with proinflammatory factors. Poult. Sci. 2022;101:101725. doi: 10.1016/j.psj.2022.101725.", "ArticleIdList": ["10.1016/j.psj.2022.101725", "PMC8927836", "35299067"]}, {"Citation": "Friedmann Angeli J.P., Schneider M., Proneth B., Tyurina Y.Y., Tyurin V.A., Hammond V.J., Herbach N., Aichler M., Walch A., Eggenhofer E., et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 2014;16:1180\u20131191. doi: 10.1038/ncb3064.", "ArticleIdList": ["10.1038/ncb3064", "PMC4894846", "25402683"]}, {"Citation": "Liu C.Y., Wang M., Yu H.M., Han F.X., Wu Q.S., Cai X.J., Kurihara H., Chen Y.X., Li Y.F., He R.R. Ferroptosis is involved in alcohol-induced cell death in vivo and in vitro. Biosci. Biotechnol. Biochem. 2020;84:1621\u20131628. doi: 10.1080/09168451.2020.1763155.", "ArticleIdList": ["10.1080/09168451.2020.1763155", "32419644"]}, {"Citation": "Qi J., Kim J.W., Zhou Z., Lim C.W., Kim B. Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation-Mediated Cell Death in Mice. Am. J. Pathol. 2020;190:68\u201381. doi: 10.1016/j.ajpath.2019.09.011.", "ArticleIdList": ["10.1016/j.ajpath.2019.09.011", "31610178"]}, {"Citation": "Tsurusaki S., Tsuchiya Y., Koumura T., Nakasone M., Sakamoto T., Matsuoka M., Imai H., Yuet-Yin Kok C., Okochi H., Nakano H., et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10:449. doi: 10.1038/s41419-019-1678-y.", "ArticleIdList": ["10.1038/s41419-019-1678-y", "PMC6579767", "31209199"]}, {"Citation": "Ho C.H., Huang J.H., Sun M.S., Tzeng I.S., Hsu Y.C., Kuo C.Y. Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis. Evid Based Complement. Alternat. Med. 2021;2021:6671129. doi: 10.1155/2021/6671129.", "ArticleIdList": ["10.1155/2021/6671129", "PMC8241502", "34239589"]}, {"Citation": "Kong Z., Liu R., Cheng Y. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. Biomed. Pharmacother. 2019;109:2043\u20132053. doi: 10.1016/j.biopha.2018.11.030.", "ArticleIdList": ["10.1016/j.biopha.2018.11.030", "30551460"]}, {"Citation": "Kuo C.Y., Chiu V., Hsieh P.C., Huang C.Y., Huang S.J., Tzeng I.S., Tsai F.M., Chen M.L., Liu C.T., Chen Y.R. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis. J. Pharmacol. Sci. 2020;144:172\u2013182. doi: 10.1016/j.jphs.2020.07.014.", "ArticleIdList": ["10.1016/j.jphs.2020.07.014", "32811746"]}, {"Citation": "Sui M., Jiang X., Chen J., Yang H., Zhu Y. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway. Biomed. Pharmacother. 2018;106:125\u2013133. doi: 10.1016/j.biopha.2018.06.060.", "ArticleIdList": ["10.1016/j.biopha.2018.06.060", "29957462"]}, {"Citation": "Wang L., Zhang Z., Li M., Wang F., Jia Y., Zhang F., Shao J., Chen A., Zheng S. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. IUBMB Life. 2019;71:45\u201356. doi: 10.1002/iub.1895.", "ArticleIdList": ["10.1002/iub.1895", "30321484"]}, {"Citation": "Yi J., Wu S., Tan S., Qin Y., Wang X., Jiang J., Liu H., Wu B. Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis. Cell Death Discov. 2021;7:374. doi: 10.1038/s41420-021-00768-7.", "ArticleIdList": ["10.1038/s41420-021-00768-7", "PMC8643357", "34864819"]}, {"Citation": "Zhang Z., Wang X., Wang Z., Zhang Z., Cao Y., Wei Z., Shao J., Chen A., Zhang F., Zheng S. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells. Biofactors. 2021;47:801\u2013818. doi: 10.1002/biof.1764.", "ArticleIdList": ["10.1002/biof.1764", "34129254"]}, {"Citation": "Li Y., Jin C., Shen M., Wang Z., Tan S., Chen A., Wang S., Shao J., Zhang F., Zhang Z., et al. Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway. Free Radic. Biol. Med. 2020;160:845\u2013859. doi: 10.1016/j.freeradbiomed.2020.09.008.", "ArticleIdList": ["10.1016/j.freeradbiomed.2020.09.008", "32947011"]}, {"Citation": "Shen M., Guo M., Li Y., Wang Y., Qiu Y., Shao J., Zhang F., Xu X., Yin G., Wang S., et al. m(6)A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells. Free Radic. Biol. Med. 2022;182:246\u2013259. doi: 10.1016/j.freeradbiomed.2022.02.028.", "ArticleIdList": ["10.1016/j.freeradbiomed.2022.02.028", "35248719"]}, {"Citation": "Su Y., Zhao D., Jin C., Li Z., Sun S., Xia S., Zhang Y., Zhang Z., Zhang F., Xu X., et al. Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15-LO. Oxid Med. Cell Longev. 2021;2021:3456725. doi: 10.1155/2021/3456725.", "ArticleIdList": ["10.1155/2021/3456725", "PMC8683180", "34925691"]}, {"Citation": "Wang Z., Li M., Liu Y., Qiao Z., Bai T., Yang L., Liu B. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein responseinduced upregulation of CHAC1 expression. Oncol. Rep. 2021;46:240. doi: 10.3892/or.2021.8191.", "ArticleIdList": ["10.3892/or.2021.8191", "PMC8485000", "34558645"]}, {"Citation": "Cui Z., Wang H., Li S., Qin T., Shi H., Ma J., Li L., Yu G., Jiang T., Li C. Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism. J. Pharmacol. Sci. 2022;148:73\u201385. doi: 10.1016/j.jphs.2021.09.008.", "ArticleIdList": ["10.1016/j.jphs.2021.09.008", "34924133"]}, {"Citation": "Li Z.J., Dai H.Q., Huang X.W., Feng J., Deng J.H., Wang Z.X., Yang X.M., Liu Y.J., Wu Y., Chen P.H., et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol. Sin. 2021;42:301\u2013310. doi: 10.1038/s41401-020-0478-3.", "ArticleIdList": ["10.1038/s41401-020-0478-3", "PMC8026986", "32699265"]}, {"Citation": "Jin M., Shi C., Li T., Wu Y., Hu C., Huang G. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system. Biomed. Pharmacother. 2020;129:110282. doi: 10.1016/j.biopha.2020.110282.", "ArticleIdList": ["10.1016/j.biopha.2020.110282", "32531676"]}, {"Citation": "Chang W.T., Bow Y.D., Fu P.J., Li C.Y., Wu C.Y., Chang Y.H., Teng Y.N., Li R.N., Lu M.C., Liu Y.C., et al. A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways. Oxid. Med. Cell Longev. 2021;2021:7689045. doi: 10.1155/2021/7689045.", "ArticleIdList": ["10.1155/2021/7689045", "PMC7803406", "33488943"]}, {"Citation": "Gao G., Xie Z., Li E.W., Yuan Y., Fu Y., Wang P., Zhang X., Qiao Y., Xu J., Holscher C., et al. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis. J. Nat. Med. 2021;75:540\u2013552. doi: 10.1007/s11418-021-01491-4.", "ArticleIdList": ["10.1007/s11418-021-01491-4", "33590347"]}, {"Citation": "Yang Y., Chen J., Gao Q., Shan X., Wang J., Lv Z. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. Toxicology. 2020;445:152599. doi: 10.1016/j.tox.2020.152599.", "ArticleIdList": ["10.1016/j.tox.2020.152599", "32976958"]}, {"Citation": "Wang M., Liu C.Y., Wang T., Yu H.M., Ouyang S.H., Wu Y.P., Gong H.B., Ma X.H., Jiao G.L., Fu L.L., et al. (+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis. Cell Death Dis. 2020;11:781. doi: 10.1038/s41419-020-02961-5.", "ArticleIdList": ["10.1038/s41419-020-02961-5", "PMC7502081", "32951003"]}, {"Citation": "Wang Y., Chen Q., Shi C., Jiao F., Gong Z. Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress. Mol. Med. Rep. 2019;20:4081\u20134090. doi: 10.3892/mmr.2019.10660.", "ArticleIdList": ["10.3892/mmr.2019.10660", "PMC6797988", "31545489"]}, {"Citation": "He P., Hua H., Tian W., Zhu H., Liu Y., Xu X. Holly (Ilex latifolia Thunb.) Polyphenols Extracts Alleviate Hepatic Damage by Regulating Ferroptosis Following Diquat Challenge in a Piglet Model. Front. Nutr. 2020;7:604328. doi: 10.3389/fnut.2020.604328.", "ArticleIdList": ["10.3389/fnut.2020.604328", "PMC7770127", "33385007"]}, {"Citation": "Dai C., Li H., Wang Y., Tang S., Velkov T., Shen J. Inhibition of Oxidative Stress and ALOX12 and NF-kappaB Pathways Contribute to the Protective Effect of Baicalein on Carbon Tetrachloride-Induced Acute Liver Injury. Antioxidants. 2021;10:976. doi: 10.3390/antiox10060976.", "ArticleIdList": ["10.3390/antiox10060976", "PMC8235740", "34207230"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "22"}, {"Year": "2022", "Month": "5", "Day": "27"}, {"Year": "2022", "Month": "5", "Day": "27"}, {"Year": "2022", "Month": "6", "Day": "10", "Hour": "1", "Minute": "22"}, {"Year": "2022", "Month": "6", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["35684103", "PMC9182636", "10.3390/nu14112303", "nu14112303"]}}], "PubmedBookArticle": []}